Top compounds associated with response to RNF165


Feature Type Standardized
Nominal ANOVA
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.064 0.04
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.083 0.04
mRNA BIRB 0796 GDSC1000 pan-cancer AAC -0.072 0.04
mRNA CI-976 CTRPv2 pan-cancer AAC 0.093 0.04
mRNA MG-132 CTRPv2 pan-cancer AAC -0.14 0.05
mRNA HG-5-113-01 GDSC1000 pan-cancer AAC 0.09 0.05
mRNA UNC0638 CTRPv2 pan-cancer AAC 0.083 0.05
mRNA BI-2536 CTRPv2 pan-cancer AAC 0.073 0.05
mRNA FQI-2 CTRPv2 pan-cancer AAC 0.077 0.05
mRNA Bortezomib gCSI pan-cancer AAC 0.12 0.05
Download CSV